anahita sharma - slides - oral presentation
TRANSCRIPT
![Page 1: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/1.jpg)
‘ R e v o l v i n g d o o r p a t i e n t s ’ — t h e a f t e r c a r e a n d monitoring of patients with alcohol dependence syndrome in a primary care setting in Salford
![Page 2: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/2.jpg)
1,059,210 admissions(2013-14)
![Page 3: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/3.jpg)
PoisoningMental and behavioral disordersAlcoholic polyneuropathyAlcoholic myopathyAlcoholic liver diseaseGastritisCardiomyopathy
Acute and chronic pancreatitisAccidents, injuryChronic liver diseaseDiabetes mellitusEpilepsy and status epilepticusFallsPeptic ulcerationOesophageals varicesHeart faiure
F u l l y attributable
P a r t i a l l y attributable
![Page 4: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/4.jpg)
Alcohol Dependence Syndrome (ICD-10)> 3 of the following criteria:
✤ Strong desire or sense of compulsion to take the substance;
✤ Difficulties in controlling substance-taking behaviours;
✤ Physiological withdrawal state when substance use has ceased or has been reduced, or taking the substance with the intention of relieving or avoiding withdrawal symptoms;
✤ Evidence of tolerance;
✤ Progressive neglect of alternative pleasures or interests;
✤ Persisting with substance use despite clear evidence of overly harmful consequences.
![Page 5: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/5.jpg)
> 15 units / day
Treatment Goal: Abstinence
Prevalence — 5.9%
![Page 6: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/6.jpg)
![Page 7: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/7.jpg)
94 patientsAlcohol dependence syndrome
Female33,33 %
Male66,67 %
![Page 8: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/8.jpg)
Unemployment — of working age,87% affected by alcohol
![Page 9: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/9.jpg)
Psychiatric co-morbidity 63% of all patients
78% of whom, depressed43%, anxious
![Page 10: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/10.jpg)
50% of all patientsattended A&E for alcohol-related reasons
74%
![Page 11: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/11.jpg)
Alcohol Use Disorders Identification Test(AUDIT)
Comprehensive screening tool (1995, WHO)
✤ Frequency
✤ Impaired control
✤ Morning drinking
✤ Injury
✤ Blackouts
✤ Guilt
8.5% — AUDIT > 20, documented at least once 5% — AUDIT 16-20, documented at least once
![Page 12: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/12.jpg)
99% — units consumed were recorded as well as other metrics, e.g. ‘Ex-drinker’, ‘Light drinker’, ‘Moderate drinker’, ‘Harmful drinker’
![Page 13: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/13.jpg)
79% offered ‘structured brief in te rven t ion ’ ( i .e . hea l th education)
![Page 14: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/14.jpg)
8 1 % h a d h a d r o u t i n e biochemical tests
Useful for screening for:
Macrocytic anaemia Deranged LFTs↑ GGT
![Page 15: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/15.jpg)
PRECARE
16%
Self-help groups
51%T h i a m i n e (Vitamin B1)
52%
Psychological inpute.g. primary care mental health, psychiatric referral
![Page 16: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/16.jpg)
Documented referrals to
![Page 17: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/17.jpg)
% of all patients who accessed at least once
![Page 18: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/18.jpg)
AFTERCARE
80%
Psychological inputfor those with pre-existing co-morbid psychiatric disorders
100% prescriptions maintained by G.P.
Acamprosate ( c a m p r a l ) , d i s u l f i r a m ( A n t a b u s e ) , thiamine
![Page 19: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/19.jpg)
83% of all patients who received a medically assisted withdrawal, or other support, from CAT, relapsed.
This was revealed through A&E attendances for alcohol-related reasons in 41% of these patients.
![Page 20: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/20.jpg)
Final review of records — at the end of the audit:
40 out of the 94 patients had achieved abstinence or self-moderation when last screened
![Page 21: Anahita Sharma - Slides - Oral Presentation](https://reader031.vdocuments.us/reader031/viewer/2022030313/58ecd6071a28ab6e628b4661/html5/thumbnails/21.jpg)
✤ Systematically screen all patients using the AUDIT
✤ Use abbreviated AUDIT tools (FAST, AUDIT-C), in consultations, where relevant
✤ Signpost patients to assisted withdrawal services and open-access group therapies
✤ Continue following up prescriptions of relapse prevention medications initiated by CAT
✤ Ensure all these are reviewed on 6-monthly basis by biochemical assessment
✤ Continue to refer those with persistent psychological symptoms for psychological and psychiatric support
✤ Follow up patients after assisted withdrawal using low-intensity measures (e.g. telephone calls), for at least 3 years afterwards